Neuren Pharmaceuticals Pink Sheet Forecast - Relative Strength Index
| NURPF Stock | USD 12.02 0.18 1.48% |
Neuren Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Neuren Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 29th of January 2026, the relative strength index (RSI) of Neuren Pharmaceuticals' share price is approaching 34. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Neuren Pharmaceuticals, making its price go up or down. Momentum 34
Sell Stretched
Oversold | Overbought |
Using Neuren Pharmaceuticals hype-based prediction, you can estimate the value of Neuren Pharmaceuticals Limited from the perspective of Neuren Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Neuren Pharmaceuticals after-hype prediction price | USD 12.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neuren |
Neuren Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Neuren price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuren using various technical indicators. When you analyze Neuren charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 34.52 | 34.52 |
| Check Neuren Pharmaceuticals Volatility | Backtest Neuren Pharmaceuticals | Information Ratio |
Neuren Pharmaceuticals Trading Date Momentum
| On January 28 2026 Neuren Pharmaceuticals Limited was traded for 12.02 at the closing time. The highest daily price throughout the period was 12.02 and the lowest price was 12.02 . The daily volume was 4.2 K. The net trading volume on 01/28/2026 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
| Compare Neuren Pharmaceuticals to competition |
Other Forecasting Options for Neuren Pharmaceuticals
For every potential investor in Neuren, whether a beginner or expert, Neuren Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neuren Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neuren. Basic forecasting techniques help filter out the noise by identifying Neuren Pharmaceuticals' price trends.View Neuren Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Neuren Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Neuren Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuren Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Neuren Pharmaceuticals pink sheet market strength indicators, traders can identify Neuren Pharmaceuticals Limited entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 12.02 | |||
| Day Typical Price | 12.02 | |||
| Price Action Indicator | (0.09) | |||
| Period Momentum Indicator | (0.18) | |||
| Relative Strength Index | 34.52 |
Neuren Pharmaceuticals Risk Indicators
The analysis of Neuren Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neuren Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neuren pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.02 | |||
| Standard Deviation | 3.02 | |||
| Variance | 9.11 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neuren Pharmaceuticals
The number of cover stories for Neuren Pharmaceuticals depends on current market conditions and Neuren Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neuren Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neuren Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Neuren Pink Sheet
Neuren Pharmaceuticals financial ratios help investors to determine whether Neuren Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neuren with respect to the benefits of owning Neuren Pharmaceuticals security.